(FMIL) Fidelity New Millennium - Overview
Etf: Equity, Technology, Innovation, Small-Cap, Mid-Cap
Dividends
| Dividend Yield | 1.19% |
| Yield on Cost 5y | 2.41% |
| Yield CAGR 5y | 4.11% |
| Payout Consistency | 90.4% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 15.6% |
| Relative Tail Risk | 3.78% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.59 |
| Alpha | 0.01 |
| Character TTM | |
|---|---|
| Beta | 0.961 |
| Beta Downside | 0.993 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.72% |
| CAGR/Max DD | 1.09 |
Description: FMIL Fidelity New Millennium January 21, 2026
FMIL is a U.S.-based exchange-traded fund that aims to capture long-term growth by investing in small- and medium-sized companies that stand to benefit from structural shifts-such as technological advances, product innovation, demographic changes, and evolving social attitudes-across both domestic and foreign markets.
According to its most recent filing, FMIL carries an expense ratio of roughly 0.30% and manages about $1.2 billion in assets, with an annual turnover near 30% and a weighted-average market capitalization of $5 billion; its largest sector exposures are information technology, health care, and consumer discretionary, sectors that are being driven by accelerating digital adoption, an aging population, and rising consumer spending.
A deeper dive on ValueRay can help you gauge how these trends translate into the fund’s risk-adjusted performance.
What is the price of FMIL shares?
Over the past week, the price has changed by -1.76%, over one month by -1.47%, over three months by +3.44% and over the past year by +13.95%.
Is FMIL a buy, sell or hold?
What are the forecasts/targets for the FMIL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 64.5 | 20% |
FMIL Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 985.2m USD (985.2m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 985.2m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 985.2m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.46% (E(985.2m)/V(985.2m) * Re(9.46%) + (debt-free company))
Discount Rate = 9.46% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)